Investor profile
o2h Ventures has backed 12 European tech companies across 13 funding rounds between 2021 and 2025, joining rounds totalling €91M. Most active in Healthtech and Deeptech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| PhoreMost | UK | 1 | €39M |
| ViaNautis | UK | 1 | €23M |
| PharmEnable | UK | 1 | €6.9M |
| Pencil Biosciences | UK | 1 | €6.5M |
| Kuano | UK | 2 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| PhoreMost | Series B | €39M | 2024-09 |
| ViaNautis | Series A | €23M | 2023-11 |
| PharmEnable | Seed | €6.9M | 2023-05 |
| Pencil Biosciences |
| €3.3M |
| Spirea | UK | 1 | €2.9M |
| Oxford Drug Design | UK | 1 | €2.6M |
| Sanome | UK | 1 | €2.3M |
| CardiaTec | UK | 1 | €1.6M |
| Monument Therapeutics | UK | 1 | €1.0M |
| Atelerix | UK | 1 | €894k |
| Five Alarm Bios | UK | 1 | €568k |
| Seed |
| €6.5M |
| 2023-09 |
| Spirea | Other | €2.9M | 2022-06 |
| Oxford Drug Design | Other | €2.6M | 2022-05 |
| Sanome | Other | €2.3M | 2021-09 |
| Kuano | Seed | €2.1M | 2023-09 |
| CardiaTec | Pre-Seed | €1.6M | 2022-07 |
| Kuano | Seed | €1.2M | 2021-07 |
